TerraBioGen Recieves Additional NRC-IRAP Funding

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, is pleased to announce that it has
received approval for additional funding from the National Research Council of
Canada Industrial Research Assistance Program (NRC-IRAP).


With the progress that the Company has made to date, NRC-IRAP is providing
further financial support for TerraBioGen's research and development efforts
with a grant of up to $36,400. This brings the total potential NRC-IRAP funding
for the identification and characterization of bioactive compounds in the
Company's products to $175,235. 


Blair Heffelfinger, President and CEO of the Company, stated, "NRC-IRAP has been
very supportive of our ongoing research and development efforts and product
innovation. This additional funding will assist us in the isolation and
characterization of additional bioactive ingredients in our products that impart
plant growth promotion and increased crop yields benefits."


About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a worldwide marketing capability to ensure market acceptance of its
products.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward looking
statements. Forward looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024